# Rocklatan vs Latanoprost Post-DSLT

> **NCT07465913** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Eye Centers of Southeast Texas** · enrollment: 36 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Rocklatan 0.02%-0.005% Ophthalmic Solution
- **DRUG:** Latanoprost 0.005% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT07465913
- **Lead sponsor:** Eye Centers of Southeast Texas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2027-05-06
- **Final completion:** 2027-05-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07465913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07465913, "Rocklatan vs Latanoprost Post-DSLT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07465913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*